Choate Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.92M | Sell |
4,302
-183
| -4% | -$81.5K | 0.04% | 147 |
|
|
2025
Q1 | $2.17M | Buy |
4,485
+19
| +0.4% | +$9.21K | 0.05% | 130 |
|
|
2024
Q4 | $1.8M | Buy |
4,466
+154
| +4% | +$62K | 0.04% | 145 |
|
|
2024
Q3 | $2.01M | Sell |
4,312
-301
| -7% | -$140K | 0.05% | 141 |
|
|
2024
Q2 | $2.16M | Sell |
4,613
-442
| -9% | -$207K | 0.06% | 128 |
|
|
2024
Q1 | $2.11M | Sell |
5,055
-10
| -0.2% | -$4.18K | 0.06% | 139 |
|
|
2023
Q4 | $2.06M | Buy |
5,065
+1,611
| +47% | +$656K | 0.06% | 125 |
|
|
2023
Q3 | $1.2M | Buy |
3,454
+1,132
| +49% | +$394K | 0.05% | 139 |
|
|
2023
Q2 | $817K | Buy |
2,322
+257
| +12% | +$90.4K | 0.03% | 161 |
|
|
2023
Q1 | $651K | Hold |
2,065
| – | – | 0.03% | 160 |
|
|
2022
Q4 | $596K | Buy |
2,065
+113
| +6% | +$32.6K | 0.04% | 166 |
|
|
2022
Q3 | $565K | Hold |
1,952
| – | – | 0.04% | 146 |
|
|
2022
Q2 | $550K | Buy |
1,952
+649
| +50% | +$183K | 0.03% | 160 |
|
|
2022
Q1 | $340K | Buy |
1,303
+64
| +5% | +$16.7K | 0.02% | 234 |
|
|
2021
Q4 | $272K | Hold |
1,239
| – | – | 0.02% | 244 |
|
|
2021
Q3 | $225K | Sell |
1,239
-812
| -40% | -$147K | 0.01% | 249 |
|
|
2021
Q2 | $414K | Buy |
2,051
+805
| +65% | +$162K | 0.03% | 193 |
|
|
2021
Q1 | $268K | Buy |
+1,246
| New | +$268K | 0.02% | 229 |
|